Borthne A, The treatment of glaucoma with propranolol (Inderal). A clinical trial., in Acta Ophthalmologica, vol. 54, n. 3, luglio 1976, pp. 291-300, PMID782144.
Kramer MS, Gorkin R, DiJohnson C, Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study, in The Hillside Journal of Clinical Psychiatry, vol. 11, n. 2, 1989, pp. 107-19, PMID2577308.
Koller WC, Herbster G, Adjuvant therapy of parkinsonian tremor, in Archives of neurology, vol. 44, n. 9, settembre 1987, pp. 921-3, PMID3619710.
Vieweg V, Pandurangi A, Levenson J, Silverman J, The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia, in Int J Psychiatry Med, vol. 24, n. 4, 1994, pp. 275-303, PMID7737786.
Kishi Y, Kurosawa H, Endo S, Is propranolol effective in primary polydipsia?, in Int J Psychiatry Med, vol. 28, n. 3, 1998, pp. 315-25, PMID9844835.
La fluvoxamina rallenta il metabolismo del propranololo, portando quindi a livelli ematici di propranololo superiori alla norma. van Harten J, Overview of the pharmacokinetics of fluvoxamine, in Clin Pharmacokinet, 29 Suppl 1, 1995, pp. 1-9, PMID8846617.